1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZFAND6 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA TMEM145 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA SYP CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA CBFA2T2 CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA KAT6A CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA UNC5A CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA N4BP2L1 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA C21orf58 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA SSFA2 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA RP11-722G7.1 CTRPv2 pan-cancer AAC 0.15 1e-05
Download CSV